<DOC>
	<DOCNO>NCT00647764</DOCNO>
	<brief_summary>Hsp90 chemical body involved promotion cancer . SNX-5422 experimental drug block Hsp90 . It evaluate safety efficacy patient cancer .</brief_summary>
	<brief_title>Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Solid tumor lymphoid malignancy refractory standard therapy measurable disease recovery Grade &lt; 1 toxicity due prior adverse event chemotherapy chemotherapy within 4 week enter study Age &gt; 18 year Karnofsy &gt; = 60 % Life expectancy &gt; 3 month normal adequate organ marrow function receive investigational agent brain metastasis uncontrolled medical illness HIV+ receive combination antiretroviral therapy significant GI disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>